Dr. Anil Bhushan, expert in immune response to senescent cells, discusses topics such as natural resistance to SARS-CoV-2, new cancer immunotherapy targets, and immune escape in colorectal cancer. The podcast explores the impact of OAS1 prenylation on COVID-19 severity, differences in immune responses in colorectal cancer tumors, and challenges in drugging cellular targets. It also covers harmful effects of senescent cells, selective depletion in adipose tissue using INKT cells, and promotes opportunities for postdoctoral fellows in science.